How to Give Calcium Correction
For acute symptomatic hypocalcemia, administer IV calcium gluconate as a 1-2 gram bolus (90-180 mg elemental calcium) over 10-20 minutes with cardiac monitoring, followed by continuous infusion of 10 grams calcium gluconate in 1 liter D5W or normal saline at 100 mL/hour, while simultaneously starting oral calcitriol 0.25-0.5 μg twice daily. 1, 2
Indications for IV Calcium
IV calcium is warranted in the following situations, regardless of absolute calcium level 1:
- Severe symptoms: seizures, laryngospasm, bronchospasm, or tetany
- Cardiac complications: prolonged QTc (>0.45s in men, >0.47s in women)
- Severe biochemical hypocalcemia: albumin-corrected calcium <7.5 mg/dL (1.9 mmol/L)
- Inability to take oral supplements or history of seizures
IV Calcium Administration Protocol
Initial Bolus Therapy
Calcium gluconate is strongly preferred over calcium chloride due to significantly lower risk of tissue necrosis if extravasation occurs 1, 2, 3:
- Dose: 1-2 grams IV calcium gluconate (90-180 mg elemental calcium)
- Preparation: Dilute in 50-100 mL of 5% dextrose or normal saline to concentration of 10-50 mg/mL 2
- Rate: Administer over 10-20 minutes
- Maximum infusion rate: DO NOT exceed 200 mg/minute in adults or 100 mg/minute in pediatric patients 2
- Monitoring: Continuous cardiac monitoring during bolus administration—rapid infusion can cause cardiac arrest 1, 2
- IV access: Use secure, large-bore IV with durable access 1
Continuous Infusion
Following the bolus, transition to continuous infusion 1:
- Preparation: Mix 10 ampules (10 grams) calcium gluconate in 1 liter of 5% dextrose or normal saline (concentration 5.8-10 mg/mL)
- Starting rate: 100 mL/hour
- Titration: Adjust based on serum calcium levels (albumin-corrected or ionized calcium preferred)
- Expected effect: 15 mg/kg elemental calcium over 4-6 hours raises serum calcium by approximately 0.5-0.75 mmol/L 1
- Goal: Restore calcium to just below normal reference range 1
Monitoring During IV Therapy
- Serum calcium: Every 6 hours initially, then daily once stable 1
- During continuous infusion: Every 1-4 hours 2
- Continuous cardiac monitoring during bolus and high-rate infusions 1
Concurrent Oral Therapy
Start oral therapy immediately alongside IV calcium 1:
Active Vitamin D
- Calcitriol: 0.25-0.5 μg twice daily (preferred), OR
- Alfacalcidol: 0.5 μg daily
Oral Calcium
- Initiate oral calcium supplementation concurrently
- Continue as IV calcium is weaned
Critical Safety Considerations
Drug Incompatibilities 2
DO NOT mix calcium gluconate with:
- Ceftriaxone: Forms precipitates; absolutely contraindicated in neonates ≤28 days
- Bicarbonate or phosphate-containing solutions: Causes precipitation
- Minocycline: Calcium complexes and inactivates the drug
Extravasation Risk
Calcium gluconate is strongly preferred over calcium chloride because:
- Calcium chloride (272 mg elemental calcium per gram) causes markedly higher risk and severity of tissue necrosis with extravasation 1, 3
- Calcium chloride should only be given via central line if used 4, 3
- If calcium chloride is necessary, use dose-equivalent amounts: 4.4 mL of 7.35% calcium chloride = 10 mL of 10% calcium gluconate 4
Essential Co-Factor Correction
Always check and correct hypomagnesemia—hypocalcemia cannot be effectively treated without adequate magnesium levels 1
Special Populations
Renal Impairment
Pregnancy
- Use albumin-corrected or ionized calcium (total calcium unreliable due to hemodilution) 1
- Monitor calcium, magnesium, phosphorus, and creatinine every 2-4 weeks 1
Chronic Management Transition
Once acute phase resolves, transition to chronic oral therapy targeting:
- Low-normal serum calcium (albumin-corrected)
- 24-hour urine calcium: <250 mg/24h (women), <300 mg/24h (men) 1
- Monitor labs every 3-12 months depending on stability 1
The evidence strongly supports this algorithmic approach, with the most recent 2025 guidelines 1 providing the clearest directive that calcium gluconate via secure IV access with cardiac monitoring represents the safest and most effective acute management strategy.